Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSinclair Pharma Regulatory News (SPH)

  • There is currently no data for SPH

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Completes £132m strategic disposal

17 Dec 2015 08:41

RNS Number : 3819J
Sinclair IS Pharma PLC
17 December 2015
 



 

Sinclair IS Pharma plc

("Sinclair" or the "Company")

Completes £132m strategic disposal of non-aesthetics business to Alliance Pharma plc

 

Creates a fast growth, high margin pure-play differentiated aesthetics company

 

· Delivering a product portfolio operating in fast growing markets underpinned by geographic expansion and new product introductions

· Highly differentiated aesthetics brands addressing unmet market need for effective, high quality, minimally-invasive treatments

· Simplified business structure with a strong balance sheet with pro forma net cash of £82m to support future growth

· The Company remains in an offer period

 

London, 17 December 2015 further to the announcement on 26 November 2015, Sinclair IS Pharma plc (SPH.L), ("Sinclair" or the "Company") the international specialty pharma company, is pleased to announce it has completed the strategic disposal of its non-aesthetics business to Alliance Pharma plc for a total upfront cash consideration of £132m as well as sales-related royalty payments relating to Flammacerium US.

 

The terms of the transaction announced on 26 November 2015 remain unchanged.

 

Sinclair is now a pure-play highly differentiated aesthetics company, operating in a high growth, self-pay market with high gross margin. Sinclair's balance sheet has now been transformed, leaving the Company with a pro-forma net cash position of £82m to invest in future growth opportunities and to cover milestone payments from historical acquisitions. Sinclair has built a strong portfolio of differentiated, complementary aesthetics technologies, which are experiencing significant growth, targeting unmet clinical needs for effective, high quality, longer duration, natural looking and minimally-invasive treatments. The Company is planning entry to multiple new geographic markets and line extension launches over the next few years.

 

As announced on 26 November 2015 the Company remains in an offer period under the framework provided by a formal sales process under the Takeover Code.

 

Tomorrow the Company will formally change its name to Sinclair Pharma plc, the TIDM will remain SPH.L.

 

For further information please contact:

 

Sinclair IS Pharma plc

Tel: +44 (0) 20 7467 6920

Chris Spooner

Alan Olby

 

Rothschild

Tel: +44 (0) 20 7280 5000

Julian Hudson

 

Peel Hunt LLP (NOMAD and Broker)

Tel: +44 (0) 20 7418 8900

James Steel

Oliver Jackson

 

Media enquiries

 

FTI Consulting

Tel: +44 (0) 203 727 1000

Ben Atwell

Brett Pollard

 

 

Notes to Editors:

 

About Sinclair IS Pharma plc - www.sinclairpharma.com 

Sinclair IS Pharma plc is an international company that operates in the fast growth, high gross margin, global aesthetics market. Sinclair has built a strong portfolio of differentiated, complementary aesthetics technologies, which are experiencing significant growth, targeting unmet clinical needs for effective, high quality, longer duration, natural looking and minimally-invasive treatments. The Company is planning entry to multiple new geographic markets and line extension launches over the next few years. The group has an established sales and marketing presence in the leading EU markets' and a rapidly growing International division concentrated on the Emerging Markets through long term multi-product, multi-country, sales, marketing and distribution deals with key strategic partners.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DISPKODNFBDKFBD
Date   Source Headline
28th Mar 20177:15 amRNSHardman Research: Much more streamlined
27th Mar 201710:30 amRNSAppointment of Joint Broker
22nd Mar 20175:29 pmRNSHolding(s) in Company
21st Mar 20177:00 amRNSPreliminary Results
21st Mar 20177:00 amRNSSettlement Agreement with Sinclair Pharma plc
17th Jan 20179:27 amRNSHardman Research: Demanding targets exceeded
17th Jan 20177:00 amRNSPre-Close Trading Update
5th Jan 20177:15 amRNSNotification of full year trading update
17th Nov 201610:39 amRNSDirector/PDMR Shareholding
17th Nov 201610:36 amRNSAdditional Listing
8th Nov 20169:08 amRNSHardman Research: Poised for a long term uplift
8th Nov 20167:05 amRNSHardman Research: Poised for a long term uplift
18th Oct 20165:55 pmRNSHolding(s) in Company
13th Oct 20164:46 pmRNSHolding(s) in Company
5th Oct 20167:00 amRNSDirector/PDMR Shareholding
3rd Oct 20163:56 pmRNSHolding(s) in Company
30th Sep 20162:29 pmRNSTotal Voting Rights
29th Sep 20162:24 pmRNSHolding(s) in Company
28th Sep 20162:23 pmRNSAdditional Listing
27th Sep 20164:14 pmRNSDirector/PDMR Shareholding
27th Sep 20164:12 pmRNSDirector/PDMR Shareholding
26th Sep 20165:04 pmRNSAdditional Listing
22nd Sep 20162:02 pmRNSHolding(s) in Company
21st Sep 20167:00 amRNSHalf-year Report
1st Sep 20167:00 amRNSRestructuring Programme and Board Change
22nd Aug 20167:00 amRNSNotice of Results
19th Jul 20167:00 amRNSTrading Statement
2nd Jun 20167:00 amRNSPresenting at Jefferies Healthcare Conference
31st May 20167:00 amRNSDirector Dealing
24th May 20169:52 amRNSPurchase of shares by Chief Financial Officer
23rd May 20167:00 amRNSDirector Dealing
20th May 201611:43 amRNSOption Awards
20th May 201610:16 amRNSDirector Dealings
20th May 20167:00 amRNSUS Collaboration and Positive Trading Update
19th May 20164:35 pmRNSUS Collaboration and Positive Trading Update
19th May 20162:15 pmRNSForm 8.3 - SINCLAIR PHARMA PLC
19th May 201612:50 pmRNSForm 8.3 - Sinclair Pharma PLC
19th May 201612:00 pmRNSForm 8.5 (EPT/RI) - Sinclair Pharma Plc
18th May 201612:00 pmRNSForm 8.5 (EPT/RI) - Sinclair Pharma Plc
18th May 201611:24 amRNSForm 8.3 - Sinclair Pharma plc
17th May 201612:00 pmRNSForm 8.5 (EPT/RI) - Sinclair Pharma Plc
16th May 201612:00 pmRNSForm 8.5 (EPT/RI) - Sinclair Pharma Plc
13th May 20161:35 pmRNSForm 8.3 - Sinclair Pharma plc
12th May 201612:40 pmRNSForm 8.3 - Sinclair Pharma plc
11th May 201612:00 pmRNSForm 8.5 (EPT/RI) - Sinclair Pharma Plc
10th May 20162:13 pmRNSForm 8.3 - SINCLAIR PHARMA PLC
10th May 20161:56 pmRNSForm 8.3 - Sinclair Pharma plc
9th May 201612:00 pmRNSForm 8.5 (EPT/RI) - Sinclair Pharma Plc
6th May 201612:00 pmRNSForm 8.5 (EPT/RI) - Sinclair Pharma Plc
6th May 201611:25 amPRNForm 8.3 - Sinclair Pharma Plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.